Follow The Filings

BIIB position history

The shares of Biogen (BIIB) that CAUSEWAY CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q4: 281,702 shares, $43M, 0.98% of portfolio, New
  2. 2025 Q1: 433,517 shares, $59M, 1.2% of portfolio, Add +53.9%
  3. 2025 Q2: 493,355 shares, $62M, 0.98% of portfolio, Add +13.8%
  4. 2025 Q3: 567,518 shares, $79M, 1.1% of portfolio, Add +15.0%
  5. 2025 Q4: 521,101 shares, $92M, 1.3% of portfolio, Reduce −8.2%
  6. 2026 Q1: 280,783 shares, $51M, 0.63% of portfolio, Reduce −46.1%
  7. 2026 Q2: 278,283 shares, $60M, 0.65% of portfolio, Reduce −0.9%
Holdings date Value % of holdings Shares Filing date All 13F holders